Clinical Study

Lisdexamfetamine In Binge Eating Disorder (Bed): Fmri Effects

Posted Date: May 9, 2017

  • Investigator: Susan Lynn Mcelroy
  • Co-Investigator: Susan Spoon
  • Specialties:
  • Type of Study: Drug

The purpose of this research study is to gather information about the effects of Lisdexamfetamine treatment on brain function in Binge Eating Disorder (BED) patients undergoing 12 weeks of open-label treatment. To do so, we will use magnetic resonance ima

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Are A Woman, 18 To 55 Years Of Age, Inclusive, You Have Been Diagnosed With Bed, And You Are Currently Seeking Treatment For Bed At Lindner Center Of Hope. Bed Is The Most Common Eating D

Keywords:

Approved Medication For Binge Eating, Binge, Binge Eating, Lisdexamfetamine, Vyvanse

For More Information:

Anna
Guerdjikova
anna.guerdjikova@lindnercenter.org

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.